Discover why Crispr Therapeutics AG is a strong buy with FDA-approved Casgevy, a promising pipeline, and major growth ...
News Medical on MSN
Genome-edited immune cell therapy shows promise for treating aggressive blood cancer
A groundbreaking new treatment using genome-edited immune cells, developed by scientists at UCL (University College London) ...
Almost two thirds of patients with T-cell acute lymphoblastic leukaemia involved in a clinical trial of the treatment are now ...
Two researchers at the University of California, Davis, have been awarded a VinFuture Prize in recognition of their work ...
A cutting-edge base-edited CAR T-cell therapy is opening a revolutionary new frontier for patients battling aggressive T-cell leukemia.
The north Solano County city has enough water and power capacity to cover current investments from biotechnology firms. Those are key to Vacaville’s asset-based economic development approach.
7don MSN
Are university policies holding science back? Study shows how patenting boosts pure research
When UC Berkeley biochemist Jennifer Doudna first began studying how bacteria fight virus infections, she had no idea it ...
Five years ago this month, in November 2020, medical history was made at London-based contract research organisation, Richmond Pharmacology, when a patient received the first CRISPR therapy delivered ...
A new treatment using genome-edited immune cells, developed by scientists at UCL (University College London) and Great Ormond ...
As reported in the Wall Street Journal, Armstrong has now officially entered the designer-baby business by funding heritable ...
A session at the AHA Scientific Sessions 2025 focused on the latest groundbreaking trails in cardiometabolic therapies.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback